Your browser doesn't support javascript.
loading
Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study.
Lloyd, C E; Sartorius, N; Ahmed, H U; Alvarez, A; Bahendeka, S; Bobrov, A E; Burti, L; Chaturvedi, S K; Gaebel, W; de Girolamo, G; Gondek, T M; Guinzbourg, M; Heinze, M G; Khan, A; Kiejna, A; Kokoszka, A; Kamala, T; Lalic, N M; Lecic-Tosevski, D; Mannucci, E; Mankovsky, B; Müssig, K; Mutiso, V; Ndetei, D; Nouwen, A; Rabbani, G; Srikanta, S S; Starostina, E G; Shevchuk, M; Taj, R; Valentini, U; van Dam, K; Vukovic, O; Wölwer, W.
Affiliation
  • Lloyd CE; The Open University, Milton Keynes, UK.
  • Sartorius N; Association for the Improvement of Mental Health Programmes, Geneva, Switzerland.
  • Ahmed HU; Child Adolescent & Family Psychiatry, National Institute of Mental Health (NIMH), Dhaka, Bangladesh.
  • Alvarez A; Servicio de Endocrinologia y Medicina Nuclear del Hospital Italiano de Buenis Aires, Buenis Aires, Argentina.
  • Bahendeka S; The Mother Kevin Post Graduate Medical School, Uganda Martyrs University, Kampala, Uganda.
  • Bobrov AE; Federal Medical Research Centre for Psychiatry and Narcology, Moscow, Russia.
  • Burti L; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Chaturvedi SK; National Institute of Mental Health & Neurosciences, Bangalore, India.
  • Gaebel W; Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
  • de Girolamo G; Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Gondek TM; European Psychiatric Association - Early Career Psychiatrists Committee, Wroclaw, Poland.
  • Guinzbourg M; Servicio de Psiquiatría del Hospital Italiano de Buenos Aires, Buenis Aires, Argentina.
  • Heinze MG; Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Khan A; Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Kiejna A; WSB University, Torun, Poland.
  • Kokoszka A; University of Lower Silesia, Wroclaw, Poland.
  • Kamala T; II Department of Psychiatry, Medical University of Warsaw, Warszawa, Poland.
  • Lalic NM; Diabetes Centre and Jnana Sanjeevini Medical Centre, Bangalore, India.
  • Lecic-Tosevski D; Clinic for Endocrinology, Belgrade University School of Medicine, Serbian Academy of Sciences and Arts, Belgrade, Serbia.
  • Mannucci E; Serbian Academy of Sciences and Arts, Belgrade, Serbia.
  • Mankovsky B; Diabetology - Careggi Teaching Hospital and University of Florence, 50141, Florence, Italy.
  • Müssig K; Department of Diabetology, National Medical Academy for Postgraduate Education, Kyiv, Ukraine.
  • Mutiso V; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
  • Ndetei D; Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Nouwen A; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Rabbani G; Africa Mental Health Research and Training Foundation, Nairobi, Kenya.
  • Srikanta SS; University of Nairobi, Africa Mental Health Research and Training Foundation, Nairobi, Kenya.
  • Starostina EG; Middlesex University, London, UK.
  • Shevchuk M; Neurodevelopmental Protection Trustee Board, Dhaka, Bangladesh.
  • Taj R; Samatvam Endocrinology Diabetes Centre and Jnana Sanjeevini Medical Centre, Bangalore, India.
  • Valentini U; Department of Endocrinology, Moscow Regional Clinical and Research Institute, Moscow, Russia.
  • van Dam K; Department of Diabetology, National Medical Academy for Postgraduate Education, Kyiv, Ukraine.
  • Vukovic O; Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Wölwer W; Diabetology Unit, ASST Spedali Civili, Brescia, Italy.
Epidemiol Psychiatr Sci ; 29: e134, 2020 Jun 02.
Article in En | MEDLINE | ID: mdl-32484148
ABSTRACT

AIMS:

To examine the factors that are associated with changes in depression in people with type 2 diabetes living in 12 different countries.

METHODS:

People with type 2 diabetes treated in out-patient settings aged 18-65 years underwent a psychiatric assessment to diagnose major depressive disorder (MDD) at baseline and follow-up. At both time points, participants completed the Patient Health Questionnaire (PHQ-9), the WHO five-item Well-being scale (WHO-5) and the Problem Areas in Diabetes (PAID) scale which measures diabetes-related distress. A composite stress score (CSS) (the occurrence of stressful life events and their reported degree of 'upset') between baseline and follow-up was calculated. Demographic data and medical record information were collected. Separate regression analyses were conducted with MDD and PHQ-9 scores as the dependent variables.

RESULTS:

In total, there were 7.4% (120) incident cases of MDD with 81.5% (1317) continuing to remain free of a diagnosis of MDD. Univariate analyses demonstrated that those with MDD were more likely to be female, less likely to be physically active, more likely to have diabetes complications at baseline and have higher CSS. Mean scores for the WHO-5, PAID and PHQ-9 were poorer in those with incident MDD compared with those who had never had a diagnosis of MDD. Regression analyses demonstrated that higher PHQ-9, lower WHO-5 scores and greater CSS were significant predictors of incident MDD. Significant predictors of PHQ-9 were baseline PHQ-9 score, WHO-5, PAID and CSS.

CONCLUSION:

This study demonstrates the importance of psychosocial factors in addition to physiological variables in the development of depressive symptoms and incident MDD in people with type 2 diabetes. Stressful life events, depressive symptoms and diabetes-related distress all play a significant role which has implications for practice. A more holistic approach to care, which recognises the interplay of these psychosocial factors, may help to mitigate their impact on diabetes self-management as well as MDD, thus early screening and treatment for symptoms is recommended.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Quality of Life / Stress, Psychological / Mass Screening / Depressive Disorder, Major / Diabetes Mellitus, Type 2 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Epidemiol Psychiatr Sci Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Quality of Life / Stress, Psychological / Mass Screening / Depressive Disorder, Major / Diabetes Mellitus, Type 2 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Epidemiol Psychiatr Sci Year: 2020 Document type: Article